Meilleure Health International Industry Group Limited (HKG:2327)
Hong Kong · Delayed Price · Currency is HKD 0.2380
0.00 (0.00%)
At close: Feb 11, 2026
HKG:2327 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 38.1 | 50.68 | 129.3 | 119.89 | 253.03 | 265.14 | |
Revenue Growth (YoY) | -54.92% | -60.81% | 7.85% | -52.62% | -4.57% | 12.93% |
Cost of Revenue | 11.38 | 22.73 | 52.09 | 53.14 | 152.1 | 153.88 |
Gross Profit | 26.72 | 27.95 | 77.21 | 66.76 | 100.93 | 111.25 |
Selling, General & Admin | 28.97 | 31.6 | 39.34 | 35.69 | 42.66 | 50.41 |
Operating Expenses | 29.17 | 31.8 | 41.83 | 35.93 | 43.58 | 50.58 |
Operating Income | -2.45 | -3.85 | 35.38 | 30.83 | 57.35 | 60.67 |
Interest Expense | -8.95 | -10.29 | -11.41 | -11.45 | -8.39 | -13.68 |
Interest & Investment Income | 22.5 | 22.5 | 19.87 | 27.21 | 13.54 | 8.58 |
Earnings From Equity Investments | -2.39 | -3.02 | -4.35 | -14.77 | -11.07 | -4.2 |
Currency Exchange Gain (Loss) | 5.44 | 4.01 | -0.24 | -5.57 | -9.94 | 5.22 |
Other Non Operating Income (Expenses) | 12.61 | 12.41 | -11.3 | 4.63 | -2.92 | 2.2 |
EBT Excluding Unusual Items | 26.77 | 21.76 | 27.95 | 30.89 | 38.57 | 58.79 |
Impairment of Goodwill | -18.5 | -18.5 | - | - | - | - |
Gain (Loss) on Sale of Investments | 1.82 | 19.38 | 5.77 | -19.24 | 31.74 | 46.43 |
Gain (Loss) on Sale of Assets | 0.06 | 0.06 | 0.48 | 0 | - | 14.07 |
Asset Writedown | 44.24 | 23.81 | 18.54 | 13.58 | 15.18 | -16.87 |
Other Unusual Items | -1.1 | -1.1 | 0.24 | 0.15 | 0.21 | 1.17 |
Pretax Income | 53.28 | 45.4 | 52.98 | 25.39 | 85.7 | 103.59 |
Income Tax Expense | 14.32 | 13.36 | 14.49 | 7.61 | 25.25 | 18.52 |
Earnings From Continuing Operations | 38.96 | 32.05 | 38.49 | 17.78 | 60.46 | 85.07 |
Minority Interest in Earnings | 0.21 | 0.44 | 2.34 | 0.04 | -0.13 | -1.63 |
Net Income | 39.17 | 32.48 | 40.83 | 17.82 | 60.32 | 83.44 |
Net Income to Common | 39.17 | 32.48 | 40.83 | 17.82 | 60.32 | 83.44 |
Net Income Growth | 25.81% | -20.45% | 129.10% | -70.46% | -27.70% | - |
Shares Outstanding (Basic) | 4,079 | 4,093 | 4,093 | 4,109 | 4,257 | 4,272 |
Shares Outstanding (Diluted) | 4,079 | 4,093 | 4,093 | 4,110 | 4,266 | 4,272 |
Shares Change (YoY) | -0.15% | -0.02% | -0.41% | -3.66% | -0.13% | 2.36% |
EPS (Basic) | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 |
EPS (Diluted) | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 |
EPS Growth | 25.52% | -20.79% | 132.01% | -69.51% | -27.69% | - |
Free Cash Flow | 62.68 | 185.86 | -137.32 | 42.14 | -89.75 | 70.44 |
Free Cash Flow Per Share | 0.01 | 0.04 | -0.03 | 0.01 | -0.02 | 0.02 |
Dividend Per Share | 0.005 | 0.004 | 0.004 | 0.016 | - | - |
Dividend Growth | 37.50% | - | -75.00% | - | - | - |
Gross Margin | 70.13% | 55.15% | 59.71% | 55.68% | 39.89% | 41.96% |
Operating Margin | -6.43% | -7.61% | 27.36% | 25.71% | 22.66% | 22.88% |
Profit Margin | 102.82% | 64.09% | 31.58% | 14.87% | 23.84% | 31.47% |
Free Cash Flow Margin | 164.53% | 366.77% | -106.20% | 35.15% | -35.47% | 26.57% |
EBITDA | -1.44 | -2.67 | 36.93 | 32.26 | 58.39 | 61.66 |
EBITDA Margin | -3.78% | -5.26% | 28.56% | 26.91% | 23.08% | 23.25% |
D&A For EBITDA | 1.01 | 1.19 | 1.55 | 1.43 | 1.04 | 0.99 |
EBIT | -2.45 | -3.85 | 35.38 | 30.83 | 57.35 | 60.67 |
EBIT Margin | -6.43% | -7.61% | 27.36% | 25.71% | 22.66% | 22.88% |
Effective Tax Rate | 26.88% | 29.42% | 27.35% | 29.96% | 29.46% | 17.88% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.